Combination of a probiotic and an antispasmodic increases quality of life and reduces symptoms in patients with irritable bowel syndrome: a pilot study
Conclusion: The results are consistent with previous studies on the use of the i3.1 probiotic formulation for the management of symptoms in IBS patients, and the addition of an antispasmodic improves its observed effects.
Source: Digestive Diseases - Category: Gastroenterology Source Type: research
More News: Clinical Trials | Gastroenterology | Irritable Bowel Syndrome | Pain | Pain Management | Probiotics | Study